Reference
Ma Q, et al. Efficacy of dose-adjusted EPOCH plus rituximab/ R-CHOP regimens and the prognosis analysis in patients with MYC, BCL2/BCL6 gene copy number gain lymphoma and double-hit lymphoma: Results from a single institution retrospective clinical study. Cancer Management and Research 11: 1363-1372, 11 Feb 2019. Available from: URL: http://doi.org/10.2147/CMAR.S192143 -China
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1747, 30 (2019). https://doi.org/10.1007/s40278-019-59671-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-59671-0